[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-452613-105":59,"doc-detail-452613-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","neuropathic-pain-polyneuropathy-and-quality-of-life-in-patients-receiving-dialysis-clinical-research","Neuropathic Pain, Polyneuropathy, and Quality of Life in Patients Receiving Dialysis - Clinical Research","","Neuropathic pain and polyneuropathy can impair quality of life in patients receiving dialysis. This observational cross-sectional study evaluated quality of life and compared electromyography (EMG) findings in patients screened positive versus negative for neuropathic pain. Seventy-four hemodialysis patients completed the Ferrans & Powers Quality of Life Index-Dialysis III, Neuropathic Pain Questionnaire, and Brief Pain Inventory-Short Form, while EMG was performed for all participants.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/neuropathic-pain-polyneuropathy-and-quality-of-life-in-patients-receiving-dialysis-clinical-research/452613/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/neuropathic-pain-polyneuropathy-and-quality-of-life-in-patients-receiving-dialysis-clinical-research/452613.png","ImageObject",300,407,{"name":92,"@type":93},"dhado","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-30",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What was the primary aim of the study?","Question",{"text":112,"@type":113},"To assess quality of life and compare EMG findings between patients screened positive and negative for neuropathic pain.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which questionnaires and tools were used to assess outcomes?",{"text":117,"@type":113},"Quality of life was measured with the Ferrans & Powers Quality of Life Index-Dialysis III, neuropathic pain with the Neuropathic Pain Questionnaire, and pain with the Brief Pain Inventory-Short Form. EMG was performed in all patients.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find regarding neuropathic pain screening and EMG results?",{"text":121,"@type":113},"NPQ screening identified 51.4% as likely to have neuropathic pain, while EMG revealed polyneuropathy in 89.2% of patients. Quality of life scores were significantly lower in the NPQ-positive group.",{"name":123,"@type":110,"acceptedAnswer":124},"Were there differences in EMG polyneuropathy types between NPQ-positive and NPQ-negative groups?",{"text":125,"@type":113},"No statistically significant differences were observed for polyneuropathy types identified via EMG between NPQ-positive and NPQ-negative groups.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},452613,1790910322,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":148,"preview_page_count":4},5909893218464,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","CLINICAL RESEARCH  \ne-ISSN 1643-3750  \n© Med Sci Monit, 2025; 31: e951360 DOI: 10. 12659/MSM.951360  \nReceived: 2025.09.02  \nAccepted: 2025.09.26  \nAvailable online: 2025.10.23  \nPublished: 2025.12.22  \nAuthors’ Contribution: Study Design A  \nData Collection B Statistical Analysis C Data Interpretation D Manuscript Preparation E Literature Search F Funds Collection G  \nABCDEFG  \nDEF  \nBCDE  \nABEF  \nDEF  \nABCD  \nCorresponding Author: Financial support: Conflict of interest:  \nNeuropathic Pain, Polyneuropathy, and Quality of Life in Patients Receiving Dialysis  \n1 Emine Esra Ergül  \n2 Hilal Büşra Ayçiçek   \n3 Serhat Hayme  \n4 Çetin Ergül  \n2 Elif Can Özdemir  \n5 Ali Veysel Kara  \n1 Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Erzincan Binali Yıldırım University, Erzincan, Türkiye  \n2 Department of Physical Medicine and Rehabilitation, Gülhane Training and Research Hospital, Ankara, Türkiye  \n3 Department of Biostatistics, Faculty of Medicine, Erzincan Binali Yıldırım University, Erzincan, Türkiye  \n4 Department of Internal Medicine, Faculty of Medicine, Erzincan Binali Yıldırım University, Erzincan, Türkiye  \n5 Department of Nephrology, Faculty of Medicine, Erzincan Binali Yıldırım University, Erzincan, Türkiye  \nEmine Esra Ergül, e-mail: [esrayilmaz50@hotmail.com](esrayilmaz50@hotmail.com)  \nNone declared  \nNone declared  \nBackground: Neuropathic pain and polyneuropathy can affect the quality of life in patients receiving dialysis. The aim of this study was to assess quality of life and to compare electromyography (EMG) findings between patients screened positive and negative for neuropathic pain.  \nMaterial/Methods: This study was designed as an observational cross-sectional study in which 74 patients receiving hemodialysis were admitted. The Ferrans & Powers Quality of Life Index-Dialysis III Version, Neuropathic Pain Questionnaire (NPQ), and Brief Pain Inventory-Short Form were completed by all patients. Additionally, EMG was performed on all patients regardless of the presence of neuropathic symptoms.  \nResults: According to the NPQ screening results, 51.4% of patients were identified as likely having neuropathic pain, whereas EMG findings revealed polyneuropathy in 89.2%(66 patients). Ferrans & Powers Quality of Life Index total and subgroup scores were compared between the NPQ-positive and NPQ-negative groups based on the screening results. Quality of life was found to be statistically significantly lower in the NPQ-positive group across all subgroups (P\u003C0.001). No statistically significant differences were observed between NPQ-positive and NPQ-negative groups regarding any of the polyneuropathy types identified via EMG (P>0.05).  \nConclusions: This study explores the association between screening-positive neuropathic pain and quality of life. Given the high prevalence of polyneuropathy on EMG even among patients without symptoms suggestive of neuropathic pain, it can be valuable to assess dialysis patients during the asymptomatic period as well.  \nKeywords: Pain • Polyneuropathies • Quality of Life • Hemodialysis, Home • Electromyography  \nFull-text PDF: [https://www.medscimonit.com/abstract/index/idArt/951360](https://www.medscimonit.com/abstract/index/idArt/951360)  \n3132  4  —  26  \nPublisher’s note: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher  \nThis work is licensed under Creative Common AttributionNonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)  \ne951360-1  \nIndexed in: [Current Contents/Clinical Medicine] [SCI Expanded] [ISI Alerting System][ISI Journals Master List] [Index Medicus/MEDLINE] [EMBASE/Excerpta Medica][Chemical Abstracts/CAS]  \nCLINICAL RESEARCH  \nErgül [E.E. et]","cbCaic6J6DONkmqv","https://ap.wps.com/l/cbCaic6J6DONkmqv","pdf",319607,"English","# Background\n# Material/Methods\n# Results\n# Conclusions\n## Introduction\n## Clinical Research","[{\"question\":\"What was the primary aim of the study?\",\"answer\":\"To assess quality of life and compare EMG findings between patients screened positive and negative for neuropathic pain.\"},{\"question\":\"Which questionnaires and tools were used to assess outcomes?\",\"answer\":\"Quality of life was measured with the Ferrans \\u0026 Powers Quality of Life Index-Dialysis III, neuropathic pain with the Neuropathic Pain Questionnaire, and pain with the Brief Pain Inventory-Short Form. EMG was performed in all patients.\"},{\"question\":\"What did the study find regarding neuropathic pain screening and EMG results?\",\"answer\":\"NPQ screening identified 51.4% as likely to have neuropathic pain, while EMG revealed polyneuropathy in 89.2% of patients. Quality of life scores were significantly lower in the NPQ-positive group.\"},{\"question\":\"Were there differences in EMG polyneuropathy types between NPQ-positive and NPQ-negative groups?\",\"answer\":\"No statistically significant differences were observed for polyneuropathy types identified via EMG between NPQ-positive and NPQ-negative groups.\"}]","Neuropathic Pain, Polyneuropathy, and Quality of Life in Patients Receiving Dialysis - Clinical Research | PDF",1790737475,18]